Mangalam Drugs And Organics Limited — Important, 29-05-2025: Updates

Mangalam Drugs and Organics has announced a board meeting to approve the financial results for the quarter and half-year. Quarterly revenue dropped to Rs 73.24 Cr from Rs 102.24 Cr year-on-year, pushing full-year sales down to Rs 318.23 Cr from Rs 368.59 Cr. Rising costs squeezed operating profit to Rs 5.55 Cr for the quarter and Rs 19.42 Cr for the year. Net profit fell sharply to Rs 0.15 Cr for Q4 but remained positive at Rs 6.92 Cr for the year versus a loss last year. The company maintains a stable asset base and moderate cash flow.